Michael Robert Martin - 11 May 2021 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role: Chief Business Officer
Signature: /s/ Michael Robert Martin
Issuer symbol: AUPH
Transactions as of: 11 May 2021
Net transactions value: +$60,400
Form type: 4
Filing time: 12 May 2021, 16:30:18 UTC
Next filing: 23 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUPH	Common Stock	Options Exercise	$60,400	+20,000	+9.9%	$3.02	221,861	11 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AUPH	Option Grant (right to buy)	Options Exercise	$0	-20,000	-100%	$0.000000^*	0	11 May 2021	Common Stock	20,000	$3.02	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date.
F2	The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date. The expiration date was extended as a result of the blackout period.